Sumitomo Dainippon Pharma Annual Report 2017
3/102

Key Figures (fiscal year ended March 31, 2017)11countries8¥411.6billion999¥80.8billion55.3%Ratio of Overseas SalesNet SalesCountries with Business Operations(Own sales channel)Research and Development CostsLate-Stage Development ProductsNo. of Participants inSocial Contribution Activities02Sumitomo Dainippon Pharma Co., Ltd. Annual Report 2017

元のページ  ../index.html#3

このブックを見る